AI IntelligenceMay 15, 2026AI Intelligence
Article
TuHURA Biosciences, an immuno-oncology company, released Q1 2026 financial results.
The company is developing novel therapies to overcome resistance to cancer immunotherapy.
Data Cube AI EditorialSource: PR Newswire
01
Source Brief
TuHURA Biosciences, an immuno-oncology company, released Q1 2026 financial results. The company is developing novel therapies to overcome resistance to cancer immunotherapy.